Celgene (CELG) option implied volatility flat; Bristol-Myers (BMY) to acquire
Tweet
Share
E-mail
Get Alerts CELG Hot Sheet
Join SI Premium – FREE
Celgene (NASDAQ: CELG) January weekly call option implied volatility is at 39, January is at 40, February is at 39; compared to its 52-week range of 22 to 57 into Bristol-Myers (BMY) to acquire in deal with equity value of approx. $74B. Call put ratio 1 call to 1 put.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PG&E Corp, Edison spike on chatter
- MongoDB (MDB) call put ratio 1 call to 1.7 puts into quarter results
- Hewlett Packard Enterprise (HPE) call put ratio 2.2 calls to 1 put into quarter results
Create E-mail Alert Related Categories
Options, Trader TalkRelated Entities
Options, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
